Почетна › Гојазност › Тексас

Kliničke studije za Гојазност u državi Тексас

57 studija za Гојазност traži učesnike na lokacijama u državi Тексас.

Gradovi u državi Тексас

Zvanični tekst studije (na engleskom)

Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

Cedar Health Research- Texas Native Health, Dallas
Cedar Health Research, LLC, Dallas
Soma Clinical Trials, LLC, Denison
и још 5

Тражи се учесникФаза 3

Узраст од 18 до 99 · Оба пола · Ажурирано 9. 11. 2026. · NCT07871409

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Bellaire Clinical Research, LLC, Bellaire
South Texas Research Institute - Brownsville, Brownsville
South Texas Clinical Research, Corpus Christi
и још 8

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351045

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Houston

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Headlands Research Brownsville, Brownsville
Velocity Clinical Research, Dallas
South Texas Research Institute - Edinburg, Edinburg
и још 5

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Pinnacle Clinical Research Georgetown, Austin
Epic Medical Research - DeSoto, DeSoto
Biopharma Informatic, LLC, Houston
и још 8

Тражи се учесникФаза 3

Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT07575399

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

Velocity Clinical Research, Dallas, Dallas
DM Clinical Research, Tomball

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07823608

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

Mercy Family Clinic, Dallas
Cedar Health Research, Fort Worth
JCCT-JUNO NW Houston, Houston
и још 4

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

IMA Clinical Research Austin, Austin
Headlands Horizons, LLC dba Headlands Research-Brownsville, Brownsville
Cedar Health Research - Texas Native Health, Dallas
и још 10

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

PlanIt Research, LLC (Monitoring Room), Houston
PlanIt Research, LLC, Houston
VIP Trials, San Antonio

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

IMA Clinical Research Austin, Austin
Diabetes and Thyroid Center of Ft. Worth, Fort Worth
Juno Research, Houston
и још 5

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Bellaire Dermatology Associates, Bellaire
Modern Research Associates, PLLC, Dallas
Center for Clinical Studies, Houston
и још 3

Тражи се учесникФаза 4

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06857942

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

IMA Clinical Research Austin, Austin
Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
Velocity Clinical Research, Dallas, Dallas
и још 5

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

UT Southwestern Medical Center, Dallas
Juno Research, Houston
Activian Clinical Research, Kingwood
и још 7

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

JCCT - Juno Bellaire Site, Bellaire
Epic Medical Research - DeSoto, DeSoto
Valley Institute of Research - Fort Worth, Fort Worth
и још 5

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07353931

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Gastroenterology Research of San Antonio, San Antonio
Southern Star Research Institute, San Antonio
Tyler Research Institute, Tyler

Тражи се учесникФаза 3

Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

FutureSearch Trials of Neurology, Austin
Sleep Therapy Research Center, San Antonio
Consano Clinical Research, LLC, Shavano Park

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07369011

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastroenterology Research of San Antonio, San Antonio
Southern Star Research Institute, San Antonio
Tyler Research Institute, Tyler

Тражи се учесникФаза 3

Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Dell Children's Medical Center - PIN, Austin
Driscoll Children's Hospital, Corpus Christi
McGovern Medical School, Houston
и још 4

Тражи се учесникФаза 3

Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Juno Research, Houston
Southern Endocrinology Associates, Mesquite
Texas Diabetes & Endocrinology, P.A., Round Rock
и још 2

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475

Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)

Fortrea Clinical Research Unit - Dallas, Dallas

Тражи се учесникФаза 1

Узраст од 18 до 70 · Оба пола · Ажурирано 2. 11. 2026. · NCT07908316

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Houston
Research Site, San Antonio
Research Site, Sugar Land
и још 1

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, DeSoto
Research Site, El Paso
Research Site, Houston
и још 5

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270

Healthy Living BEYOND Weight Study

American Heart Association, Dallas

Тражи се учесникОпсервациона студија

Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07075341

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Amarillo Medical Specialists /ID# 282380, Amarillo
Elligo Clinical Research Center /ID# 282166, Austin
JCCT - Juno Bellaire /ID# 282263, Bellaire
и још 6

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07752979

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

DM Clinical Research, Irving
DM Clinical Research - Dominion Family Healthcare, San Antonio
Tekton Research, San Antonio
и још 1

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07837973

Improving Glycemic Control With Electrical Stimulation

University of Texas at El Paso, El Paso

Тражи се учесникЗдраве особе су добродошле

Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT03947697

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Austin
ACCOMPLISH-2 Research Site, Farmers Branch
ACCOMPLISH-2 Research Site, Houston
и још 4

Тражи се учесникФаза 3Здраве особе су добродошле

Узраст од 18 до 79 · Оба пола · Ажурирано 20. 10. 2026. · NCT07654374

PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study

UT MD Anderson, Houston

Тражи се учесникФаза 2

Узраст од 18 до 39 · Оба пола · Ажурирано 20. 10. 2026. · NCT07874828

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Amarillo Medical Specialists, Amarillo
Elligo Clin Res Centre, Austin

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07607587

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

Baylor College of Medicine, Houston

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06273072

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

ICON Early Phase Services, LLC, San Antonio

Тражи се учесникФаза 1Здраве особе су добродошле

Узраст од 18 до 65 · Оба пола · Ажурирано 15. 10. 2026. · NCT07654972

A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Fortrea Clinical Research Unit, Dallas

Тражи се учесникФаза 1Здраве особе су добродошле

Узраст од 18 до 65 · Оба пола · Ажурирано 8. 10. 2026. · NCT07808073

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

IMA Clinical Research Austin, Austin
FutureSearch Trials of Dallas, Dallas
PlanIt Research, PLLC, Houston
и још 2

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07589608

A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight

Fortrea Clinical Research Unit, Dallas

Тражи се учесникФаза 1Здраве особе су добродошле

Узраст од 18 до 60 · Жене · Ажурирано 8. 10. 2026. · NCT07808060

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

IMA Clinical Research Austin, Austin
Velocity Clinical Research, Dallas, Dallas
FutureSearch Trials of Dallas, Dallas
и још 3

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT06143956

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Epic Medical Research, DeSoto
Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
Biorhythms Center for Integrative Sleep Medicine, El Paso
и још 3

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07571109

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Elligo Clinical Research Center, Austin
Johnson County Clinical Trials Juno Bellaire, Bellaire
Cedar Health Research, LLC, Dallas
и још 8

Тражи се учесникФаза 3

Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Elligo Clinical Research Center, Austin
Johnson County Clinical Trials Juno Bellaire, Bellaire
Osvaldo A Brusco MD PA, Corpus Christi
и још 1

Тражи се учесникФаза 3

Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Kailera Clinical Site, San Antonio

Тражи се учесникФаза 1Здраве особе су добродошле

Узраст од 18 до 85 · Оба пола · Ажурирано 1. 10. 2026. · NCT07793929

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

DM Clinical, Houston
DM Clinical, San Antonio
The Texas Liver Institute, San Antonio
и још 3

Тражи се учесникФаза 3

Узраст од 8 до 18 · Оба пола · Ажурирано 30. 9. 2026. · NCT07253285

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.